Infectious diseases Archives - Page 30 of 33

Infectious diseases

Clinical Articles

Children and COVID-19

It is the world-wide experience that children appear to be at low risk of experiencing symptomatic COVID-19. Because of the low numbers, there are still a number of unanswered questions with regard to the transmission and expression of the disease in this population. Many studies are currently underway, but Professor Crawford outlines the current understanding about COVID-19 in children:

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

Osteoporosis Management during COVID-19

Throughout the coming months, people living with osteoporosis will require ongoing treatment, and it is critical patients remain fully compliant with their medication and treatment for managing osteoporosis and bone health.

Expert/s: Osteoporosis Australia

Infectious diseases

Clinical Articles

Practical GP PPE

While there is little robust clinical evidence to guide the most appropriate choice and use of PPE in general practice, particularly in relation to COVID-19, knowledge about the nature of this virus can help direct efforts to prevent its spread.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

How long do you remain infectious when you have coronavirus?

One thing many of us want to know is for how long people who have SARS-CoV-2 , the virus that causes COVID-19, are able to pass it on to someone else.

Expert/s: Tambri Housen

Infectious diseases

Clinical Articles

COVID treatments – where are we?

There appears to be a myriad of potential treatments for our current health threat – COVID19. But just how real are these options? And which if any of these are likely to make it into our treatment regimens? A review just published online in JAMA gives us a neat summary of where we are up to in terms of treatment.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

Update on Understanding of COVID-19

As discussed by Prof Bernie Hudson, Director of Microbiology and Infectious Diseases at Royal North Shore Hospital, Sydney in his interview with Dr Harry Nespolon on Going Viral According to a recent analysis of COVID-19 cases among patients aged over 18 years.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

Eliminating COVID-19 too big an ask

Scott Morrison has made clear his view that any attempt to eliminate COVID-19 entirely in Australia would carry too high an economic cost, while Chief Medical Officer Brendan Murphy says such an aim would require “very aggressive” long-term border control.

Expert/s: Prof Michelle Grattan AO

Infectious diseases

Clinical Articles

Managing non-hospitalised COVID patients

Having some evidence-based guidelines on when a COVID-positive patient needs hospitalisation is likely to be welcomed by the GP currently managing these self-isolating patients.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

What’s the story with anosmia and COVID-19?

Sudden loss of smell could be a sign of COVID-19, say ENT specialists from around the world, even in the absence of other symptoms. The experts from the UK, the US and Australia are calling for anosmia to be added to the list of possible symptoms to be asked about when screening for potentially having the virus.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

A GPs legal obligations and COVID-19

The key points from Dr Harry Nespolon’s interview with Avant’s Ms Georgie Haysom, Head of Research Education and Advocacy and Dr Penny Browne, Chief Medical Officer.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

Vaccines and treatments – where are we?

While many scientists are working on developing a coronavirus vaccine, others are busy testing antiviral drugs. Vaccines are generally only effective when administered prior to infection, but antiviral agents are important because they can treat people who already have COVID-19.

Expert/s: Dr Lisa Sedger

Infectious diseases

Clinical Articles

Covert COVID

So how much are you at risk of COVID-19 from the door handle in your surgery? Or your desktop? Or the arm of the patient’s chair? Basically the question is how long can this nasty little coronavirus remain viable on the different surfaces in your practice? Well according to Clinical Microbiologist and Infectious Diseases Physician, Dr Bernie Hudson, COVID-19 can persist and be potentially dangerous up to a week on certain surfaces. Scary isn’t it?

Expert/s: Dr Linda Calabresi

Infectious diseases

Children and COVID-19

Osteoporosis Management during COVID-19

Throughout the coming months, people living with osteoporosis will require ongoing treatment, and it is critical patients remain fully compliant with their medication and treatment for managing osteoporosis and bone health.

Practical GP PPE

While there is little robust clinical evidence to guide the most appropriate choice and use of PPE in general practice, particularly in relation to COVID-19, knowledge about the nature of this virus can help direct efforts to prevent its spread.

How long do you remain infectious when you have coronavirus?

One thing many of us want to know is for how long people who have SARS-CoV-2 , the virus that causes COVID-19, are able to pass it on to someone else.

COVID treatments – where are we?

Update on Understanding of COVID-19

As discussed by Prof Bernie Hudson, Director of Microbiology and Infectious Diseases at Royal North Shore Hospital, Sydney in his interview with Dr Harry Nespolon on Going Viral According to a recent analysis of COVID-19 cases among patients aged over 18 years.

Eliminating COVID-19 too big an ask

Scott Morrison has made clear his view that any attempt to eliminate COVID-19 entirely in Australia would carry too high an economic cost, while Chief Medical Officer Brendan Murphy says such an aim would require “very aggressive” long-term border control.

Managing non-hospitalised COVID patients

Having some evidence-based guidelines on when a COVID-positive patient needs hospitalisation is likely to be welcomed by the GP currently managing these self-isolating patients.

What’s the story with anosmia and COVID-19?

A GPs legal obligations and COVID-19

The key points from Dr Harry Nespolon’s interview with Avant’s Ms Georgie Haysom, Head of Research Education and Advocacy and Dr Penny Browne, Chief Medical Officer.

Vaccines and treatments – where are we?

While many scientists are working on developing a coronavirus vaccine, others are busy testing antiviral drugs. Vaccines are generally only effective when administered prior to infection, but antiviral agents are important because they can treat people who already have COVID-19.

Covert COVID

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Abnormal LFTs – Practical Cases Expert Q&A

Tuesday 28th April, 7pm - 9pm AEST

Speaker

Prof Simone Strasser

Hepatologist; Royal Prince Alfred Hospital

Join Prof Simone Strasser for the upcoming webcast, where they will discuss with A/Prof Ralph Audehm, by means of a series of primary care case studies, the framework for interpreting abnormal liver function tests.

Infectious diseases

Throughout the coming months, people living with osteoporosis will require ongoing treatment, and it is critical patients remain fully compliant with their medication and treatment for managing osteoporosis and bone health.

While there is little robust clinical evidence to guide the most appropriate choice and use of PPE in general practice, particularly in relation to COVID-19, knowledge about the nature of this virus can help direct efforts to prevent its spread.

One thing many of us want to know is for how long people who have SARS-CoV-2 , the virus that causes COVID-19, are able to pass it on to someone else.

As discussed by Prof Bernie Hudson, Director of Microbiology and Infectious Diseases at Royal North Shore Hospital, Sydney in his interview with Dr Harry Nespolon on Going Viral According to a recent analysis of COVID-19 cases among patients aged over 18 years.

Scott Morrison has made clear his view that any attempt to eliminate COVID-19 entirely in Australia would carry too high an economic cost, while Chief Medical Officer Brendan Murphy says such an aim would require “very aggressive” long-term border control.

Having some evidence-based guidelines on when a COVID-positive patient needs hospitalisation is likely to be welcomed by the GP currently managing these self-isolating patients.

The key points from Dr Harry Nespolon’s interview with Avant’s Ms Georgie Haysom, Head of Research Education and Advocacy and Dr Penny Browne, Chief Medical Officer.

While many scientists are working on developing a coronavirus vaccine, others are busy testing antiviral drugs. Vaccines are generally only effective when administered prior to infection, but antiviral agents are important because they can treat people who already have COVID-19.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Abnormal LFTs – Practical Cases Expert Q&A

Tuesday 28th April, 7pm - 9pm AEST

Speaker

Prof Simone Strasser

Hepatologist; Royal Prince Alfred Hospital

Join Prof Simone Strasser for the upcoming webcast, where they will discuss with A/Prof Ralph Audehm, by means of a series of primary care case studies, the framework for interpreting abnormal liver function tests.